Department of Neurochemistry and Neuropharmacology, Institut d'Investigacions Biomèdiques de Barcelona, Consejo Superior de Investigaciones Científicas (CSIC), 08036 Barcelona, Spain.
CIBERSAM (Centro de Investigació Biomédica en Red de Salud Mental), 28029 Madrid, Spain.
Nat Rev Drug Discov. 2017 Jan;16(1):1-2. doi: 10.1038/nrd.2016.205. Epub 2016 Nov 4.
Despite the vast amount of research on schizophrenia and depression in the past two decades, there have been few innovative drugs to treat these disorders. Precompetitive research collaborations between companies and academic groups can help tackle this innovation deficit, as illustrated by the achievements of the IMI-NEWMEDS consortium.
尽管在过去的二十年中,针对精神分裂症和抑郁症进行了大量的研究,但针对这些疾病的创新药物却寥寥无几。企业和学术团体之间的竞争前研究合作有助于解决这一创新不足的问题,IMI-NEWMEDS 联盟的成果就证明了这一点。